Hearing Loss Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 80 years old
- People who have had ongoing tinnitus (ringing or noise in the ears that only they can hear) for at least 3 months
- People who score 38 or higher on a standard tinnitus questionnaire called the Tinnitus Handicap Inventory (THI), which measures how much tinnitus affects daily life
- People whose hearing loss in their worse ear is mild to moderate, based on a standard hearing test result of 50 dB HL or below (averaged across certain frequencies)
- People who are willing to take part and sign a consent form
- People who have normal mental health and thinking ability, and are able to follow the study process
Who may not be able to join:
- People diagnosed with Ménière's disease, conductive hearing loss (a type caused by problems in the outer or middle ear), or tinnitus that can be heard by others (objective tinnitus)
- People with a history of epilepsy or stroke
- People diagnosed with acoustic neuroma (a type of non-cancerous tumour affecting the hearing nerve)
- People with severe permanent inner-ear hearing loss
- People who have metal objects in their body from surgery or injury, including pacemakers, nerve stimulators, artificial metal heart valves, certain aneurysm clips, metal fragments in the eye, cochlear implants, metal joint replacements, or fixed metal plates and pins
- People with other metal implants, dentures, contraceptive coils, or insulin pumps where the trial doctors have assessed there to be a risk from the brain stimulation treatment used in this study (called rTMS)
- People currently taking certain medications, including drugs for dizziness, antipsychotics, anti-anxiety medications, anti-epileptic drugs, or medications known to be harmful to hearing
- People with a recent history of alcohol or drug misuse
- People with Bell's palsy (sudden weakness or paralysis on one side of the face)
- People who have had an acute ear infection in the last month
- People who are unable to cooperate with or complete the study process
- People who have taken part in another clinical trial within the last month
- People with any condition that may affect their safety or ability to follow the study requirements
- People whom the study doctor considers unsuitable for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Huawei Li, PhD, Eye and ENT Hospital of Fudan University
Phone: +86-021-64377134-2033
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Tinnitus Handicap Inventory (THI); Tinnitus Handicap Inventory (THI); Tinnitus Handicap Inventory (THI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.